TearCare Treatment for Dry Eyes
Understanding TearCare and Dry Eye Disease
Most chronic dry eye is not simply a lack of moisture in the eye. It is often caused by a problem with tiny oil-producing glands inside the eyelids, and TearCare is specifically designed to treat that underlying issue. Understanding the connection between these glands and your symptoms helps explain why TearCare works when other treatments fall short.
Your eyelids contain roughly 25 to 40 meibomian glands that release a thin oil with every blink. This oil coats the surface of your tears and prevents them from evaporating too quickly. When these glands become clogged with thick, hardened oil, a condition called meibomian gland dysfunction (MGD) develops. MGD is the root cause of dry eye in the majority of patients, and it is the primary condition that TearCare is designed to treat.
Over-the-counter eye drops add temporary moisture to the eye surface but do not address the gland blockages that are causing the problem. At-home warm compresses can help soften blocked oils, but they cool down too quickly to reach the sustained therapeutic temperature needed to fully clear the glands. TearCare delivers consistent, precisely controlled heat that is far more effective than either of these approaches.
TearCare is well suited for adults who experience ongoing dry eye symptoms such as burning, grittiness, stinging, redness, or vision that fluctuates throughout the day. It is especially beneficial for people who spend extended time on digital screens, wear contact lenses, or have already tried drops and compresses without meaningful improvement. Your eye care provider will evaluate your gland health to confirm whether TearCare is the right fit for your situation.
Dry eye symptoms are often made worse by aging, hormonal changes, certain medications, air conditioning, wind exposure, and prolonged screen use. These factors contribute to inflammation and gland blockages that make the condition progressively harder to manage. By restoring healthy oil flow, TearCare helps break this cycle and reduce the evaporative dry eye that underlies most chronic cases.
How the TearCare Procedure Works
TearCare uses a two-step process that combines targeted heat therapy with gentle professional gland clearing. The procedure is performed in our office by trained eye care professionals and typically takes about 30 minutes from start to finish. Most patients find it comfortable and even relaxing.
Small, flexible heating devices called SmartLids are placed gently over your closed eyelids. These pads deliver steady, controlled warmth at a consistent therapeutic temperature for approximately 12 minutes, which is precisely calibrated to soften hardened oils inside the glands without harming surrounding tissue. Unlike a warm compress that cools within minutes, the SmartLids maintain an even, effective temperature throughout the entire heating phase.
Once the heating phase is complete, your provider uses a specialized instrument to apply gentle pressure along the eyelid margins. This process, called gland expression, clears the softened material from each blocked gland so that healthy oils can flow freely again. The expression step takes only a few minutes per eye and may feel like mild pressure, but it is not considered painful by most patients.
One distinctive feature of TearCare is that the flexible SmartLids allow you to keep your eyes open and blink naturally during treatment. This open-eye design feels more comfortable and natural compared to systems that hold the eyelids closed. The pads are also flexible enough to conform to a wide range of eyelid shapes, and built-in sensors continuously monitor temperature to maintain both safety and effectiveness throughout the session.
Immediately following the procedure, many patients notice that their eyes feel more moist and comfortable. Vision may be mildly blurry for a short period right after treatment, which is completely normal and typically resolves within minutes to hours. Some patients can even see the cleared oil being expressed from the glands during the expression step, which is a visible sign that the treatment is working.
Benefits and Potential Side Effects
TearCare has been shown in clinical studies to produce meaningful, lasting improvements in dry eye symptoms and patient quality of life. As with any medical procedure, it is helpful to understand both what you can expect to gain and the small risks involved. Overall, TearCare has a strong safety profile when performed by a trained professional.
Many patients experience significant relief lasting several months to a year or more after just one TearCare session. Reducing or eliminating daily dependence on artificial tears is a common outcome. Contact lens wearers often report improved comfort and longer wearing time, while others find that activities such as reading and screen use become much easier to sustain.
Beyond physical comfort, TearCare often helps patients re-engage with activities they had been avoiding. This can include reading for extended periods, working at a computer without frequent interruptions, enjoying time outdoors, and wearing eye makeup without irritation. Many patients also notice that nighttime dryness and discomfort improve, leading to better overall sleep quality.
Side effects from TearCare are generally mild and brief. The most common experiences include minor eyelid redness, tenderness around the treatment area, or slight swelling, all of which typically resolve within 24 hours. Some patients notice mild light sensitivity or a temporary feeling of pressure immediately after the procedure. Serious complications are rare when TearCare is performed by a qualified eye care provider.
TearCare and other in-office heat therapies for MGD, such as LipiFlow, work on the same principle of warming blocked glands to allow expression of trapped oils. TearCare's open-eye design and flexible pad technology offer a comfortable, adaptable experience that suits a wide range of patients. Compared to at-home warm compresses, TearCare delivers the sustained therapeutic temperature and professional expression that are needed to fully clear the glands rather than simply softening them temporarily.
TearCare System Efficacy and Clinical Validation
Clinical studies demonstrate that the TearCare System is an effective, noninvasive treatment for evaporative dry eye disease caused by meibomian gland dysfunction. The system works by applying localized, software-controlled thermal heat at roughly 41°C to 45°C to the eyelids, which is immediately followed by a manual gland expression performed by your eye doctor to clear out the hardened oils. Among the notable studies validating its efficacy is the six-month SAHARA randomized controlled trial, which found that two TearCare treatments were clinically superior to using twice-daily Restasis eye drops for improving tear breakup time and meibomian gland function.
Another major study validating this treatment is the OLYMPIA Trial, which established that a single TearCare procedure safely and significantly alleviates both the signs and symptoms of dry eye disease. During this randomized controlled trial, patients experienced rapid and sustained relief that was highly effective for resolving their daily discomfort. Furthermore, a specific analysis from the trial indicated that patients suffering from advanced or severe meibomian gland dysfunction actually experienced greater and more clinically meaningful symptom improvement with TearCare, when compared directly to LipiFlow.
The clinical utility and robust peer-reviewed data behind the TearCare System align perfectly with the latest international guidelines for dry eye management. In 2025, the Tear Film and Ocular Surface Society published the highly anticipated TFOS DEWS III Management and Therapy Report, which evaluates the best evidence-based approaches for treating ocular surface disease. Due to its demonstrated safety and efficacy, localized heat therapy combined with manual expression is highly recognized within these global reports as a validated step in the successful management of meibomian gland dysfunction.
Extensive clinical research has consistently confirmed that the TearCare procedure is incredibly safe, presenting with minimal to no device-related adverse events during and after the treatment process. In terms of durability, multiple robust studies highlight that the symptom relief and improvement in meibomian gland health can last up to 12 months or longer after the initial treatment sessions. If you are exploring this treatment, please let me know if you would like me to help you find a local provider, compare insurance coverage costs, or provide a list of questions to ask your eye doctor.
TearCare vs. LipiFlow: What the Clinical Research Shows
If you are exploring advanced dry eye options, you may have heard of both the TearCare and LipiFlow systems. Both utilize localized thermal therapy to clear blocked oil glands, but recent clinical data highlights significant benefits for patients who choose TearCare, particularly those suffering from more advanced meibomian gland obstruction.
A landmark multicenter, randomized-controlled trial published in Clinical Ophthalmology (Holland et al., 2022) evaluated 235 subjects to compare the effectiveness of a single TearCare treatment against a single LipiFlow treatment. After a 1-month post-treatment follow-up, researchers found that the TearCare system significantly improved dry eye disease symptoms across multiple standardized clinical questionnaires (OSDI, SANDE, and ED).
Most notably, for patients experiencing more severe gland obstruction, TearCare performed statistically better than LipiFlow. In this severe subgroup, TearCare achieved a significantly greater reduction in overall dry eye symptom frequency and delivered superior improvements in the patient's quality of vision. This clinical evidence demonstrates that TearCare's unique, adaptable design provides exceptional, powerful symptom relief when you need it most.
What to Expect at Your Appointment
Knowing what happens before, during, and after your TearCare visit can help you feel prepared and at ease. Your entire appointment typically takes about 45 minutes, including the evaluation, the procedure itself, and a brief post-treatment discussion with your provider. There is no significant downtime, and most patients return to their normal routine the same day.
Before your appointment, remove all eye makeup and avoid applying heavy creams or moisturizers near your eyes. Your provider will examine your eyelids and glands to confirm that TearCare is appropriate for your specific condition. Imaging of your meibomian glands may be taken to establish a baseline and allow your progress to be tracked over time.
You will be seated comfortably while your provider carefully positions the SmartLids on your eyelids. The heating phase is monitored continuously for your safety, and you are free to relax with your eyes open or closed during this time. Once the heating is complete, the expression step is performed gland by gland along both upper and lower eyelid margins.
After your session, avoid rubbing your eyes for the remainder of the day. Your provider may recommend specific lubricating drops or a simple at-home routine to support your recovery and extend your results. Most patients can return to work and normal daily activities right away, though swimming, hot tubs, and vigorous exercise are best avoided for the first 24 hours.
A follow-up appointment is typically scheduled within two to four weeks to evaluate how your glands are responding and how your symptoms have changed. Because MGD is a chronic condition that tends to progress over time, your provider may recommend a maintenance treatment plan to sustain your results and help prevent symptoms from returning. Regular monitoring is an important part of getting the most out of TearCare long-term.
Frequently Asked Questions
Below are answers to questions our patients frequently ask about TearCare. If you have additional questions after reading, our team is happy to help you determine whether this treatment is right for you.
Our Belleville, NJ office is located at 50 Newark Ave #107, right next to the Clara Maass Medical Center. Positioned in a highly dense pocket of Northern New Jersey, our clinic is incredibly easy to reach for patients seeking advanced dry eye relief from surrounding major cities. Under normal traffic conditions, we are within a convenient 15-minute drive from five of the area's largest population centers:
- Newark, NJ: We sit directly on the border of North Newark. You can reach us from downtown Newark via Washington Ave or Route 21 in just 7–10 minutes (~4.5 miles).
- Jersey City, NJ: Via nearby Route 7 (Belleville Turnpike) or the NJ Turnpike, the western edges of Jersey City are a quick 11–15 minute zip away (~7.5 miles).
- Paterson, NJ: Taking Route 21 North brings you straight up the river to Paterson in roughly 13–15 minutes (~10.1 miles).
- East Orange, NJ: Easily accessible in just 7–10 minutes via local arteries like Franklin Ave or the Garden State Parkway (~3.8 miles).
- Irvington, NJ: A straightforward 12–15 minute drive using local routes or the Garden State Parkway (~7.2 miles).
The duration of relief varies from person to person and depends on factors such as the severity of your MGD, your age, lifestyle habits, and environmental exposures. Many patients enjoy meaningful improvement for several months to over a year. Your provider will help you determine whether periodic maintenance sessions make sense as part of your long-term dry eye management plan.
Yes, TearCare is FDA-cleared as a safe and effective device for the treatment of meibomian gland dysfunction. Clinical data support its use for improving dry eye symptoms and gland function. TearCare is not appropriate for everyone, including patients with active eye infections, recent eye surgery, or certain conditions affecting the eye surface, which is why a thorough evaluation is always completed before treatment.
TearCare is frequently used as part of a broader dry eye management plan rather than as a standalone solution. Combining it with other therapies often produces better and longer-lasting outcomes. Depending on your individual needs, your provider might recommend complementary treatments alongside TearCare, such as the following:
- Lubricating eye drops or gels for on-demand comfort between sessions
- Prescription anti-inflammatory eye drops to address underlying eyelid inflammation
- Omega-3 fatty acid supplements to support oil gland health from the inside
- Intense Pulsed Light (IPL) therapy for additional anti-inflammatory benefits
Your provider will help you build a plan tailored to the specific causes and severity of your dry eye.
If your dry eye symptoms are not fully relieved after TearCare, this does not mean treatment has failed. MGD can be stubborn, and some patients benefit from a follow-up session or an adjustment to their overall treatment plan. It is also possible that other factors, such as allergies, eyelid inflammation, or an unrelated condition, are contributing to your symptoms. Open and ongoing communication with your provider is the best way to find the most effective path forward for your eye health.
The cost of TearCare varies depending on the provider and the specifics of your treatment plan. Insurance coverage is not guaranteed, though some plans may provide benefits if the procedure is deemed medically necessary. Our team can help you verify your coverage and discuss available payment options so that cost does not become a barrier to getting the care you need.
Response time differs from patient to patient. Some people notice their eyes feel more comfortable within the first few days, while others experience a more gradual improvement over several weeks as their glands begin producing healthier oils. Full results are generally apparent within two to six weeks following treatment. Your follow-up appointment is an important opportunity to assess your progress and make any needed adjustments.
Find Relief with Expert Dry Eye Care
At Associated Eye Physicians & Surgeons, our team is dedicated to helping patients find real, lasting relief from dry eye disease using the most advanced treatments available. We take time to understand your symptoms, evaluate your gland health, and build a personalized plan that addresses the root cause of your discomfort. If you are ready to explore whether TearCare is right for you, we welcome you to schedule a consultation at any of our convenient locations across New Jersey. Let us help you get back to seeing and feeling your best.
You have a professional excellent service
Kenneth Nelson
Staff nice and friendly. Dr. Liva is a great doctor. Always pleased with visits.
David Lima
Dr. Garranna was very professional, straight forward and honest throughout the whole process. It has been 3 months since my surgery and I am maintaining 20/15 vision. I highly recommend Dr. Garrana to anyone who might be interested in LASIK surgery.
Chandan S.
Dr. Garrana is fantastic! She gave very clear and thoughtful instructions for pre and post surgery. she is very responsive even outside of office hours. I Would highly recommend if anyone wants to get lasik surgery.
Lynn W.
We love the Doctors and staff at Associated Eye Physicians in Belleville!! My husband and I have been patients for years with Drs. Hosler and Lister and Eileen, their assistant. I recently had cataract and retina surgery and knew l was going to be treated with the best and most compassionate care. The Doctors and staff truly care for their patients!
Kathy DeCecco